yahoo_financeOriginal article
Mirum's Livmarli Meets Phase III Goal in Ultra-Rare Liver Diseases
Phase 3positiveLivmarliPositive
AI Analysis
Summary
Mirum announced that Livmarli met its Phase III primary goal in ultra-rare liver diseases, representing a positive clinical advancement for the program.
Clinical Trial Data
Phase
3
Primary Endpoint
Met
Outcome Details
Livmarli met Phase III goal in ultra-rare liver diseases
Importance:7/10
Sentiment:
0.80
Phase 3rare diseaseliver diseasepositive trial result
Related Companies
Read the original article
Published by yahoo_finance on October 13, 2026 1:41 PM